C4 Therapeutics, Inc. business relationships

Companies named in C4 Therapeutics, Inc.’s 10-K filed 2026-02-26, and public companies whose annual reports name C4 Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.6 / 10
AI naming: <1 / 100
Agent readiness: 35 / 100
AI adoption: 0 / 100

Named in C4 Therapeutics, Inc.’s annual report 9

Roche GroupSales channel7.7
“Finally, we are eligible to receive tiered royalties ranging from mid-single digit to mid-teen percentages on net sales of products sold by Roche pursuant to its exercise of its option rights, subject to certain reductions.” SEC filing
Merck & Co., Inc. (MRK)Licensor7.7
“Merck KGaA Collaboration and License Agreement” SEC filing
Roche GroupLicensor7.7
“We entered into an amended and restated license agreement with Roche in December 2018, or the Roche Agreement.” SEC filing
BIOGEN INC. (BIIB)Partner7.7
“In December 2018, we entered into a collaborative research and license agreement, or the Biogen Agreement, with Biogen MA, Inc., or Biogen, whereby we agreed to collaborate with Biogen and use our proprietary protein degrader platform to research, develop, and identify small molecule protein degrade...” SEC filing
Merck & Co., Inc. (MRK)Partner7.7
“In addition to our internal discovery strategy, we also have discovery programs in collaboration with our partners, Merck KGaA and Roche.” SEC filing
PFIZER INC (PFE)Partner7.7
“Similarly, our clinical supply partners, such as Pfizer in the case of elranatamab, may rely on a variety of third parties in connection with the manufacturing of their products.” SEC filing
Roche GroupPartner7.7
“• We have ongoing collaborations with Roche, Betta Pharma, and Merck KGaA.” SEC filing
PFIZER INC (PFE)Supplier7.7
“On September 30, 2025, we entered into a Clinical Trial Collaboration and Supply Agreement with Pfizer Inc., or the Pfizer Agreement.” SEC filing
Betta Pharmaceuticals Co., Ltd.Partner3.5
“License and Collaboration Agreement, dated May 29, 2023, by and between C4 Therapeutics, Inc. and Betta Pharmaceuticals Co., Ltd.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.